SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Elite football players 'more likely to develop dementia'
Fri March 17th - Elite male footballers are more likely to develop dementia than the general population, according to a Swedish study published today. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Airway transplant success

Wednesday October 23rd, 2013

A woman who received an artificial windpipe five years ago is doing well and has no complications, doctors reported today.

The first transplantation of a tissue-engineered windpipe (trachea) in a human was carried out in 2008. Cells were taken from a healthy donated trachea and then grown in the lab together with cells from the 30-year-old female recipient, Claudia Lorena Castillo Sánchez, from Colombia. This created a graft to replace a damaged left bronchus.

It allowed her to breathe immediately, and at four months it had improved her quality of life, and worked effectively with no need for treatment to prevent rejection.

Now, the team report their five-year follow-up results. In The Lancet, the team explain that the patient was followed up about every three months with a CT scan and assessment. Biopsy samples were taken every six months.

After one year, some narrowing occurred due to scar tissue and a stent was needed to maintain airway width.

"However, the tissue-engineered trachea itself remained open over its entire length, well vascularised, completely re-cellularised with respiratory epithelium, and had normal ciliary function and mucus clearance," say the team.

Her lung function and cough reflex were normal. No abnormal growths formed and no antibodies were made against the donated cells. Apart from frequent tests, "the patient had a normal social and working life," they report.

Team leader, Professor Paolo Macchiarini of the Karolinska Institutet in Stockholm, Sweden, said: "These results confirm what we - and many patients - hoped at the time of the original operation: that tissue engineered transplants are safe and effective in the long-term."

But he added that the scarring which occurred "shows that long-term biomechanical stability can be improved".

Gonfiotti, A. et al. The first tissue-engineered airway transplantation: 5-year follow-up results. The Lancet 23 October 2013 doi:10.1016/S0140-6736(13)62033-4 [abstract]

Tags: Europe | Respiratory | Transplant

Printer friendly page Printer friendly page

CATEGORIES